Eliminating Pediatric AIDS


	Each time Singathwa, who is HIV positive, looks at her children, she is thankful - because of the mothers2mothers (m2m) program, they were born without contracting HIV from her. Today, the global community is making a remarkable commitment to the over 1 million pregnant women living with HIV, like Singathwa, by launching the Global Plan to end new infections in children by 2015 and to keep mothers alive. Every year, 370,000 children are born with HIV. Nearly 90 percent of these cases are caused by mother-to-child transmission. Mother-to-child transmission is entirely preventable if addressed in an integrated and targeted way. In 2003, Johnson & Johnson embraced the vision of a world where no baby is born with HIV as the cornerstone of its philanthropic programs in HIV/AIDS whose focus is to prevent HIV and reduce the burden of AIDS on women and their families. Since then, we have committed $20 million to partners such as m2m and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) to strengthen community health systems, provide individual counseling and community support, and tackle social stigma and its consequences. Together we have reached over 2 million pregnant women with HIV testing and nearly a quarter of a million HIV+ expectant and new mothers with support and services. Our support, in combination with funds and efforts of others, has resulted in an increase in the percent of pregnant women living with HIV receive antiretroviral *(ARV)* medicines to prevent transmission from 10 percent in 2004 to 53 percent in 2009. Much more, though, still needs to be done. At this watershed moment, as the global community makes its first commitment to virtually eliminating pediatric aids by reducing new infections in children by 90 percent and keeping mothers alive, Johnson & Johnson is making a four-year, $15 million dollar commitment. The funding will focus on three areas that we believe our catalytic support can accelerate progress towards the goals of the global plan: -Psychosocial support for pregnant women and new mothers living with HIV to retain them in systems of care and ensure they receive life-saving services for themselves and their babies. -Management capacity of health leaders at national and district levels to achieve vertical elimination plans by strengthening health services especially for maternal and child health -Innovations that will enhance information and service delivery especially in the area of mobile technology This pledge continues building on a comprehensive set of commitments made by Johnson & Johnson to bring our research and development and financial resources to support the Millennium Development Goals of reducing maternal and infant mortality by 2015. Our responsibility is to the communities in which we live and the world community is woven into the fabric of Johnson & Johnson. Our philanthropic mission is to make life-changing, long-term differences in human health by addressing the world’s major health-related issues, especially the global HIV pandemic. We focus on saving and improving the lives of women and children, building the skills of people who serve community health needs and preventing disease. This is another step forward towards realizing a world where mother that are living with HIV, like Singathwa, are healthy and on treatment, and their children are HIV-free as well. To Learn More: Fact Sheet: Prevention of Mother-To-Child Transmission of HIV Our Giving in HIV/AIDS Joint United Nations Programme on AIDS The United States President’s Emergency Plan for AIDS Relief Mothers2mothers Elizabeth Glaser Pediatric AIDS Foundation US Fund for UNICEF

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2012. All Rights Reserved.

Johnson & Johnson

Home > Our Caring > Our Stories

Eliminating Pediatric AIDS

	Each time Singathwa, who is HIV positive, looks at her children, she is thankful - because of the mothers2mothers (m2m) program, they were born without contracting HIV from her. Today, the global community is making a remarkable commitment to the over 1 million pregnant women living with HIV, like Singathwa, by launching the Global Plan to end new infections in children by 2015 and to keep mothers alive. Every year, 370,000 children are born with HIV. Nearly 90 percent of these cases are caused by mother-to-child transmission. Mother-to-child transmission is entirely preventable if addressed in an integrated and targeted way. In 2003, Johnson & Johnson embraced the vision of a world where no baby is born with HIV as the cornerstone of its philanthropic programs in HIV/AIDS whose focus is to prevent HIV and reduce the burden of AIDS on women and their families. Since then, we have committed $20 million to partners such as m2m and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) to strengthen community health systems, provide individual counseling and community support, and tackle social stigma and its consequences. Together we have reached over 2 million pregnant women with HIV testing and nearly a quarter of a million HIV+ expectant and new mothers with support and services. Our support, in combination with funds and efforts of others, has resulted in an increase in the percent of pregnant women living with HIV receive antiretroviral *(ARV)* medicines to prevent transmission from 10 percent in 2004 to 53 percent in 2009. Much more, though, still needs to be done. At this watershed moment, as the global community makes its first commitment to virtually eliminating pediatric aids by reducing new infections in children by 90 percent and keeping mothers alive, Johnson & Johnson is making a four-year, $15 million dollar commitment. The funding will focus on three areas that we believe our catalytic support can accelerate progress towards the goals of the global plan: -Psychosocial support for pregnant women and new mothers living with HIV to retain them in systems of care and ensure they receive life-saving services for themselves and their babies. -Management capacity of health leaders at national and district levels to achieve vertical elimination plans by strengthening health services especially for maternal and child health -Innovations that will enhance information and service delivery especially in the area of mobile technology This pledge continues building on a comprehensive set of commitments made by Johnson & Johnson to bring our research and development and financial resources to support the Millennium Development Goals of reducing maternal and infant mortality by 2015. Our responsibility is to the communities in which we live and the world community is woven into the fabric of Johnson & Johnson. Our philanthropic mission is to make life-changing, long-term differences in human health by addressing the world’s major health-related issues, especially the global HIV pandemic. We focus on saving and improving the lives of women and children, building the skills of people who serve community health needs and preventing disease. This is another step forward towards realizing a world where mother that are living with HIV, like Singathwa, are healthy and on treatment, and their children are HIV-free as well. To Learn More: Fact Sheet: Prevention of Mother-To-Child Transmission of HIV Our Giving in HIV/AIDS Joint United Nations Programme on AIDS The United States President’s Emergency Plan for AIDS Relief Mothers2mothers Elizabeth Glaser Pediatric AIDS Foundation US Fund for UNICEF

Each time Singathwa, who is HIV positive, looks at her children, she is thankful - because of the mothers2mothers (m2m) program, they were born without contracting HIV from her.

Today, the global community is making a remarkable commitment to the over 1 million pregnant women living with HIV, like Singathwa, by launching the Global Plan to end new infections in children by 2015 and to keep mothers alive.

Every year, 370,000 children are born with HIV. Nearly 90 percent of these cases are caused by mother-to-child transmission. Mother-to-child transmission is entirely preventable if addressed in an integrated and targeted way. In 2003, Johnson & Johnson embraced the vision of a world where no baby is born with HIV as the cornerstone of its philanthropic programs in HIV/AIDS whose focus is to prevent HIV and reduce the burden of AIDS on women and their families.

Since then, we have committed $20 million to partners such as m2m and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) to strengthen community health systems, provide individual counseling and community support, and tackle social stigma and its consequences. Together we have reached over 2 million pregnant women with HIV testing and nearly a quarter of a million HIV+ expectant and new mothers with support and services. Our support, in combination with funds and efforts of others, has resulted in an increase in the percent of pregnant women living with HIV receive antiretroviral (ARV) medicines to prevent transmission from 10 percent in 2004 to 53 percent in 2009.

Much more, though, still needs to be done. At this watershed moment, as the global community makes its first commitment to virtually eliminating pediatric aids by reducing new infections in children by 90 percent and keeping mothers alive, Johnson & Johnson is making a four-year, $15 million dollar commitment.

The funding will focus on three areas that we believe our catalytic support can accelerate progress towards the goals of the global plan:

    -Psychosocial support for pregnant women and new mothers living      with HIV to retain them in systems of care and ensure they receive       life-saving services for themselves and their babies.

    -Management capacity of health leaders at national and district levels to      achieve vertical elimination plans by strengthening health services      especially for maternal and child health

    -Innovations that will enhance information and service delivery      especially in the area of mobile technology

This pledge continues building on a comprehensive set of commitments made by Johnson & Johnson to bring our research and development and financial resources to support the Millennium Development Goals of reducing maternal and infant mortality by 2015.

Our responsibility is to the communities in which we live and the world community is woven into the fabric of Johnson & Johnson. Our philanthropic mission is to make life-changing, long-term differences in human health by addressing the world’s major health-related issues, especially the global HIV pandemic. We focus on saving and improving the lives of women and children, building the skills of people who serve community health needs and preventing disease.

This is another step forward towards realizing a world where mother that are living with HIV, like Singathwa, are healthy and on treatment, and their children are HIV-free as well.

To Learn More:
Fact Sheet: Prevention of Mother-To-Child Transmission of HIV
Our Giving in HIV/AIDS
Joint United Nations Programme on AIDS
The United States President’s Emergency Plan for AIDS Relief
Mothers2mothers
Elizabeth Glaser Pediatric AIDS Foundation
US Fund for UNICEF

Employees